Table 1.
DRM of PI | DRM of RTI | ||||||||
---|---|---|---|---|---|---|---|---|---|
Sample number | Subtypea | HIV RNA (log cp/ml) | Type | Major | Minor | Others | NRTIs | NNRTIs | Others |
014 | B | 3.07 | Single | D30N, M46I, I54V, V82A, N88D | L10F, L33I, A71V, T74S | I13V, L19I, A22V, E35D, M36I, R41K, I62V, L63P, Q92K, I93L | M41L, L74I, V118I, M184V, T215Y | None | V35K, T39A, K43Q, K122E, I135T, I142T, Q207E, R211K |
015 | B | 3.34 | Single | None | None | T12S, I15V, L63P | None | None | K13R, K122E, T200I |
016 | B | 2.83 | Single | None | None | T12S, I15V, L63P | None | None | K13R, K122E, T200I |
026 | B | 4.70 | 30% mix | (M46ML, V82VT, L90LM)b | (A71AV, T74TS)b | (L10LH, I15VI, K20KR, E35ED, M36MI, N37NE, K43KR, R57RK, D60ED, I62IV, L63P, I64IV, I72IV, Q92EQ, I93IL)b | (D67DN, K70KR, V118VI, M184MV, L210LF, T215TF, K219KE)b | None | (V35VT, T39TA, V60IV, K64KR, K122KE, I135TI, D123DE, M164VM, Q174H, D177DE, Q197QK, T200IA, I202IV, Q207E, R211KR, F214FL)b |
028 | B | 4.82 | 10% mix | ||||||
029 | B | 5.09 | 50% mix |
Subtype was identified by the NCBI genotyping tool.
First amino acid harbored in the majority, second one in the minority (e.g., M46ML, the majority is “M” and the minority is “L”).
DRM, drug-resistance mutation; PI, protease inhibitor; RTI, reverse transcriptase inhibitor; NRTIs, nucleoside analogue reverse transcriptase inhibitors; NNRTIs, nonnucleoside analogue reverse transcriptase inhibitors; Single, single variant.